Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Zhongguo shi yan xue ye xue za zhi
Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
Number of Patients: 5
Published: October 10, 2021
View publication
Summary: This study analyzed the safety and effectiveness of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH).

The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.

Journal: Blood advances
Published: August 24, 2021
View publication
Summary: The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.

The Clinical Characteristics and Prognosis of Patients with Acute Myeloid Leukemia Combine Paroxysmal Nocturnal Hemoglobinuria.

Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 07, 2021
View publication
Summary: The Clinical Characteristics and Prognosis of Patients with Acute Myeloid Leukemia Combine Paroxysmal Nocturnal Hemoglobinuria.

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination.

Journal: Blood advances
Published: July 13, 2021
View publication
Summary: Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination.

Diagnosis of congenital hemolytic anemia by comprehensive gene analysis: significance and limitations.

Journal: The Japanese journal of clinical hematology
Published: July 12, 2021
View publication
Summary: Diagnosis of congenital hemolytic anemia by comprehensive gene analysis: significance and limitations.

Current treatment of paroxysmal nocturnal hemoglobinuria and prospects for new therapeutic agents in the future.

Journal: The Japanese journal of clinical hematology
Published: June 10, 2021
View publication
Summary: Current treatment of paroxysmal nocturnal hemoglobinuria and prospects for new therapeutic agents in the future.

Novel therapeutics for paroxysmal nocturnal hemoglobinuria.

Journal: The Japanese journal of clinical hematology
Published: June 10, 2021
View publication
Summary: Novel therapeutics for paroxysmal nocturnal hemoglobinuria.

Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.

Journal: Annals of hematology
Published: May 14, 2021
View publication
Summary: Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.

Advances in Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria.

Journal: Transplantation and cellular therapy
Published: April 12, 2021
View publication
Summary: Advances in Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria.

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.

Condition: Paroxysmal Nocturnal Hemoglobinuria
Journal: The New England journal of medicine
Treatment Used: Pegcetacoplan versus Eculizumab
Number of Patients: 80
Published: March 17, 2021
View publication
Summary: The study compared the outcomes between pegcetacoplan versus eculizumab in paroxysmal nocturnal hemoglobinuria.

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Journal: Pharmacological reviews
Published: March 10, 2021
View publication
Summary: Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMT.

Condition: Fanconi Anemia
Journal: American journal of hematology
Treatment Used: Haplo-Identical or Mismatched Unrelated Donor Hematopoietic Cell Transplantation
Number of Patients: 123
Published: February 19, 2021
View publication
Summary: This study compared haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia.
Showing 1-12 of 38